Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

NEWS

print
November 2016: awareness month for lung cancer (World Health Organization)

November 2016: awareness month for lung cancer (World Health Organization)

Νοέμβριος The Bioanalytical-GenoTypos offers accredited services genetic analysis in accordance with the international standard ISO 15189.   Participates with excellent p...

A.E: 27th National Congress of Haematology

A.E: 27th National Congress of Haematology

ΒιοΑναλυτική-ΓενόΤυπος The organizing and Scientific Committee of the 27th National Conference chose asAimatologikoy oral communication ...

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.